Home/ Supplements/ Nattokinase/ Total CardioCover

Total CardioCover

product on market Capsule Williams Nutrition Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Total CardioCover
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Amla extract
250 mg
25 mg
Market median: 100.0mg (70 products)

Other Ingredients

Microcrystalline Cellulose Gelatin Dicalcium Phosphate Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Doctor’s Suggested Use: Take 2 capsules daily - 1 capsule with morning meal and 1 capsule before going to bed.

Warnings & Precautions

Precautions: Consult a health care practitioner before use if you take warfarin or other blood thinning products, or are pregnant or nursing, have a serious medical condition, or use any medications.

Keep out of reach of children.

Contains: Soy

Formulation Notes

Unconditionally guaranteed for purity and labeled potency.

Each capsule provides 1,000 FU (fibrin units) of nattokinase activity.

Clinically validated AmlaMax + NSK-SD40

Cardio health Blood pressure Cholesterol support Blood flow

GF Gluten Free

Additional Information

Almost out? Call 1-800-888-1415 or visit healthydirections.com Choose refill & save and never run out!

Store bottle with cap tightly closed in a cool, dry place.

GF Gluten Free

Metadata

Product Details

UPC / SKU6 78829 24145 6
DSLD Entry Date2023-06-22
Product TypeOther Combinations
FormCapsule
DSLD ID287849
Data Updated2026-04-11
Research

Research Evidence

4
Research Sources
45
Avg Quality
2
Rct
1
Other
1
Systematic Review
B Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Systematic Review Reviews in cardiovascular medicine 2023 PubMed DOI
C Effects of nattokinase on blood pressure: a randomized, controlled trial
Rct Hypertension research : official journal of the Japanese Society of Hypertension 2008 PubMed DOI
C A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles
Rct Scientific reports 2015 PubMed DOI
D [A clinical study on the effect of nattokinase on carotid artery atherosclerosis and hyperlipidaemia]
Other Zhonghua yi xue za zhi 2017 PubMed DOI
View all evidence for Nattokinase →
Compare

Similar Products

View all Nattokinase products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.